Literature DB >> 22901755

Gingival lymphatic drainage protects against Porphyromonas gingivalis-induced bone loss in mice.

Lilian E Mkonyi1, Athanasia Bletsa, Anne I Bolstad, Vidar Bakken, Helge Wiig, Ellen Berggreen.   

Abstract

Periodontitis is characterized by tissue destruction and bone loss mainly due to inflammatory responses after bacterial challenge of the gingiva. Gingiva is supplied with lymphatics that drain interstitial fluid and transport immune cells to the lymph nodes for antigen presentation; yet, the role of lymphatics in periodontal disease development is unknown. To investigate the lymphatic function after periodontal infection, we used K14-VEGF receptor 3-Ig (K14) mice that lack lymphatics in gingiva. Mice were orally infected with human Porphyromonas gingivalis and observed for 42 days. The infected K14 mice developed significantly more bone loss than the wild-type mice, and were associated with an increased number of macrophages and major histocompatibility complex class II antigen-presenting cells in the bone resorptional areas. The infected transgenic mice expressed a significant higher periodontal level of several proinflammatory cytokines, whereas the plasma level of P. gingivalis IgG was significantly lower than in the wild-type mice. No differences were found in immune cell distribution in draining lymph nodes between the strains. Our results show that a strong periodontal inflammatory response and a weakened systemic humoral B-cell response took place in K14 mice after infection. We conclude that gingival lymphatics protect against P. gingivalis-induced periodontitis, and we speculate that they are critical in the protection by clearance of infection and by promotion of humoral immune responses.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901755     DOI: 10.1016/j.ajpath.2012.05.027

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  7 in total

1.  FOXO1 deletion reduces dendritic cell function and enhances susceptibility to periodontitis.

Authors:  Wenmei Xiao; Guangyu Dong; Sandra Pacios; Maher Alnammary; Laura A Barger; Yu Wang; Yingying Wu; Dana T Graves
Journal:  Am J Pathol       Date:  2015-04       Impact factor: 4.307

Review 2.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

Review 3.  Resolution of inflammation in periodontitis: a review.

Authors:  Jing Huang; Xinjie Cai; Yanjing Ou; Yi Zhou; Yining Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

Review 4.  Genes Critical for Developing Periodontitis: Lessons from Mouse Models.

Authors:  Teun J de Vries; Stefano Andreotta; Bruno G Loos; Elena A Nicu
Journal:  Front Immunol       Date:  2017-10-27       Impact factor: 7.561

5.  Polymicrobial infection with major periodontal pathogens induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null) mice.

Authors:  Mercedes F Rivera; Ju-Youn Lee; Monika Aneja; Vishalkant Goswami; Liying Liu; Irina M Velsko; Sasanka S Chukkapalli; Indraneel Bhattacharyya; Hao Chen; Alexandra R Lucas; Lakshmyya N Kesavalu
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

6.  VEGFR-2 reduces while combined VEGFR-2 and -3 signaling increases inflammation in apical periodontitis.

Authors:  Anca Virtej; Panagiota Papadakou; Hajime Sasaki; Athanasia Bletsa; Ellen Berggreen
Journal:  J Oral Microbiol       Date:  2016-09-19       Impact factor: 5.474

7.  Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis.

Authors:  Carla Alvarez; Salwa Suliman; Rawan Almarhoumi; Maria Elena Vega; Carolina Rojas; Gustavo Monasterio; Mario Galindo; Rolando Vernal; Alpdogan Kantarci
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.